Key result
EXCOR Pediatric VAD remains the only reliable option for small children with advanced HF.
Why the study?
There is an increasing use of VADs for advanced heart failure in pediatrics, but there remains a strong need for fully implantable pumps suitable for single ventricle physiology.
Highlights the current reliance on the EXCOR Pediatric VAD for small children and the unmet need for fully implantable devices suitable for single ventricle physiology.
Answers are grounded in this paper and cite their sources.
Supports ongoing EXCOR reliance in neonates and infants; leaves open urgent development of fully implantable pediatric VADs for single-ventricle physiology.
: Increasing use of VADs has facilitated a leading edge in management of advanced heart failure either as a bridge to transplantation or as a bridge to myocardial recovery. In newborns and small children, the EXCOR Pediatric VAD remains the only reliable option. In some patients ventricular unloading may lead to complete myocardial recovery. There is a strong need for pumps that are fully implantable, suitable for single ventricle physiology, such as the right ventricle.
No takes yet. Share an insight, caveat, or question.
Hetzer et al. (2019) conducted a review in Advanced heart failure. Pediatric ventricular assist devices (EXCOR Pediatric VAD) was evaluated. The EXCOR Pediatric VAD remains the only reliable option for newborns and small children with advanced heart failure, highlighting a strong need for fully implantable pumps.
Synapse has enriched 10 related papers. Consider them for comparative context: